nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—SCN11A—melanoma	0.466	0.684	CbGaD
Rufinamide—SCN10A—melanoma	0.175	0.257	CbGaD
Rufinamide—ALB—Vemurafenib—melanoma	0.0496	0.359	CbGbCtD
Rufinamide—ALB—melanoma	0.0403	0.0592	CbGaD
Rufinamide—CYP2E1—Dacarbazine—melanoma	0.0393	0.285	CbGbCtD
Rufinamide—CYP3A4—Temozolomide—melanoma	0.0284	0.205	CbGbCtD
Rufinamide—CYP3A4—Vemurafenib—melanoma	0.0156	0.113	CbGbCtD
Rufinamide—CYP3A4—Docetaxel—melanoma	0.00534	0.0386	CbGbCtD
Rufinamide—Status epilepticus—Temozolomide—melanoma	0.00267	0.0473	CcSEcCtD
Rufinamide—Aggression—Bleomycin—melanoma	0.000849	0.015	CcSEcCtD
Rufinamide—Disturbance in attention—Temozolomide—melanoma	0.000726	0.0129	CcSEcCtD
Rufinamide—Weight decreased—Vemurafenib—melanoma	0.000699	0.0124	CcSEcCtD
Rufinamide—Infestation—Vemurafenib—melanoma	0.000689	0.0122	CcSEcCtD
Rufinamide—Infestation NOS—Vemurafenib—melanoma	0.000689	0.0122	CcSEcCtD
Rufinamide—Gait disturbance—Carmustine—melanoma	0.000667	0.0118	CcSEcCtD
Rufinamide—Coordination abnormal—Carmustine—melanoma	0.000663	0.0117	CcSEcCtD
Rufinamide—Gait disturbance—Temozolomide—melanoma	0.000645	0.0114	CcSEcCtD
Rufinamide—Coordination abnormal—Temozolomide—melanoma	0.000641	0.0114	CcSEcCtD
Rufinamide—Urinary incontinence—Carmustine—melanoma	0.000629	0.0111	CcSEcCtD
Rufinamide—Urinary incontinence—Temozolomide—melanoma	0.000608	0.0108	CcSEcCtD
Rufinamide—Eye disorder—Vemurafenib—melanoma	0.000578	0.0102	CcSEcCtD
Rufinamide—Cardiac disorder—Vemurafenib—melanoma	0.000574	0.0102	CcSEcCtD
Rufinamide—Mediastinal disorder—Vemurafenib—melanoma	0.000557	0.00987	CcSEcCtD
Rufinamide—Malnutrition—Vemurafenib—melanoma	0.000538	0.00954	CcSEcCtD
Rufinamide—Back pain—Vemurafenib—melanoma	0.000521	0.00922	CcSEcCtD
Rufinamide—Diplopia—Carmustine—melanoma	0.000473	0.00837	CcSEcCtD
Rufinamide—Bone disorder—Docetaxel—melanoma	0.000463	0.00821	CcSEcCtD
Rufinamide—Diplopia—Temozolomide—melanoma	0.000457	0.00809	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000455	0.00806	CcSEcCtD
Rufinamide—Ataxia—Carmustine—melanoma	0.000444	0.00787	CcSEcCtD
Rufinamide—Infection—Vemurafenib—melanoma	0.000436	0.00773	CcSEcCtD
Rufinamide—Nervous system disorder—Vemurafenib—melanoma	0.000431	0.00763	CcSEcCtD
Rufinamide—Ataxia—Temozolomide—melanoma	0.000429	0.00761	CcSEcCtD
Rufinamide—Skin disorder—Vemurafenib—melanoma	0.000427	0.00756	CcSEcCtD
Rufinamide—Weight decreased—Bleomycin—melanoma	0.000423	0.0075	CcSEcCtD
Rufinamide—Pneumonia—Bleomycin—melanoma	0.00042	0.00744	CcSEcCtD
Rufinamide—Breast disorder—Temozolomide—melanoma	0.000413	0.00731	CcSEcCtD
Rufinamide—Neutropenia—Dactinomycin—melanoma	0.000408	0.00723	CcSEcCtD
Rufinamide—Haematuria—Bleomycin—melanoma	0.000398	0.00705	CcSEcCtD
Rufinamide—Pneumonia—Dactinomycin—melanoma	0.000391	0.00693	CcSEcCtD
Rufinamide—Neutropenia—Carmustine—melanoma	0.000382	0.00677	CcSEcCtD
Rufinamide—Decreased appetite—Vemurafenib—melanoma	0.000382	0.00676	CcSEcCtD
Rufinamide—Bronchitis—Temozolomide—melanoma	0.00038	0.00673	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000379	0.00672	CcSEcCtD
Rufinamide—Fatigue—Vemurafenib—melanoma	0.000379	0.00671	CcSEcCtD
Rufinamide—Constipation—Vemurafenib—melanoma	0.000376	0.00665	CcSEcCtD
Rufinamide—Dysuria—Temozolomide—melanoma	0.000369	0.00654	CcSEcCtD
Rufinamide—Neutropenia—Temozolomide—melanoma	0.000369	0.00654	CcSEcCtD
Rufinamide—Pneumonia—Carmustine—melanoma	0.000366	0.00649	CcSEcCtD
Rufinamide—Pollakiuria—Temozolomide—melanoma	0.000365	0.00646	CcSEcCtD
Rufinamide—Weight decreased—Temozolomide—melanoma	0.000357	0.00633	CcSEcCtD
Rufinamide—Pneumonia—Temozolomide—melanoma	0.000354	0.00627	CcSEcCtD
Rufinamide—Infestation NOS—Temozolomide—melanoma	0.000352	0.00624	CcSEcCtD
Rufinamide—Infestation—Temozolomide—melanoma	0.000352	0.00624	CcSEcCtD
Rufinamide—Hepatobiliary disease—Temozolomide—melanoma	0.000333	0.0059	CcSEcCtD
Rufinamide—Sinusitis—Temozolomide—melanoma	0.00033	0.00585	CcSEcCtD
Rufinamide—Hypersensitivity—Vemurafenib—melanoma	0.000324	0.00573	CcSEcCtD
Rufinamide—Asthenia—Vemurafenib—melanoma	0.000315	0.00558	CcSEcCtD
Rufinamide—Urinary tract disorder—Temozolomide—melanoma	0.000312	0.00553	CcSEcCtD
Rufinamide—Pruritus—Vemurafenib—melanoma	0.000311	0.00551	CcSEcCtD
Rufinamide—Urethral disorder—Temozolomide—melanoma	0.00031	0.00549	CcSEcCtD
Rufinamide—Eye disorder—Carmustine—melanoma	0.000306	0.00541	CcSEcCtD
Rufinamide—Anaemia—Bleomycin—melanoma	0.000301	0.00534	CcSEcCtD
Rufinamide—Diarrhoea—Vemurafenib—melanoma	0.000301	0.00532	CcSEcCtD
Rufinamide—Eye disorder—Temozolomide—melanoma	0.000295	0.00523	CcSEcCtD
Rufinamide—Cardiac disorder—Temozolomide—melanoma	0.000293	0.0052	CcSEcCtD
Rufinamide—Leukopenia—Bleomycin—melanoma	0.000292	0.00517	CcSEcCtD
Rufinamide—Dizziness—Vemurafenib—melanoma	0.00029	0.00515	CcSEcCtD
Rufinamide—Mental disorder—Carmustine—melanoma	0.000286	0.00507	CcSEcCtD
Rufinamide—Ataxia—Docetaxel—melanoma	0.000286	0.00506	CcSEcCtD
Rufinamide—Immune system disorder—Temozolomide—melanoma	0.000285	0.00506	CcSEcCtD
Rufinamide—Mediastinal disorder—Temozolomide—melanoma	0.000285	0.00505	CcSEcCtD
Rufinamide—Malnutrition—Carmustine—melanoma	0.000285	0.00504	CcSEcCtD
Rufinamide—Anaemia—Dactinomycin—melanoma	0.000281	0.00498	CcSEcCtD
Rufinamide—Vomiting—Vemurafenib—melanoma	0.000279	0.00495	CcSEcCtD
Rufinamide—Abdominal pain upper—Docetaxel—melanoma	0.000277	0.00491	CcSEcCtD
Rufinamide—Rash—Vemurafenib—melanoma	0.000277	0.00491	CcSEcCtD
Rufinamide—Mental disorder—Temozolomide—melanoma	0.000277	0.0049	CcSEcCtD
Rufinamide—Dermatitis—Vemurafenib—melanoma	0.000277	0.0049	CcSEcCtD
Rufinamide—Back pain—Carmustine—melanoma	0.000275	0.00488	CcSEcCtD
Rufinamide—Headache—Vemurafenib—melanoma	0.000275	0.00488	CcSEcCtD
Rufinamide—Malnutrition—Temozolomide—melanoma	0.000275	0.00487	CcSEcCtD
Rufinamide—Breast disorder—Docetaxel—melanoma	0.000274	0.00486	CcSEcCtD
Rufinamide—Leukopenia—Dactinomycin—melanoma	0.000272	0.00482	CcSEcCtD
Rufinamide—Nasopharyngitis—Docetaxel—melanoma	0.000272	0.00481	CcSEcCtD
Rufinamide—Vision blurred—Carmustine—melanoma	0.000268	0.00475	CcSEcCtD
Rufinamide—Tremor—Carmustine—melanoma	0.000267	0.00472	CcSEcCtD
Rufinamide—Back pain—Temozolomide—melanoma	0.000266	0.00471	CcSEcCtD
Rufinamide—Infection—Bleomycin—melanoma	0.000264	0.00468	CcSEcCtD
Rufinamide—Anaemia—Carmustine—melanoma	0.000263	0.00466	CcSEcCtD
Rufinamide—Agitation—Carmustine—melanoma	0.000262	0.00463	CcSEcCtD
Rufinamide—Nausea—Vemurafenib—melanoma	0.000261	0.00462	CcSEcCtD
Rufinamide—Thrombocytopenia—Bleomycin—melanoma	0.000261	0.00462	CcSEcCtD
Rufinamide—Vision blurred—Temozolomide—melanoma	0.000259	0.00459	CcSEcCtD
Rufinamide—Tremor—Temozolomide—melanoma	0.000258	0.00457	CcSEcCtD
Rufinamide—Leukopenia—Carmustine—melanoma	0.000255	0.00451	CcSEcCtD
Rufinamide—Anaemia—Temozolomide—melanoma	0.000254	0.0045	CcSEcCtD
Rufinamide—Anorexia—Bleomycin—melanoma	0.000254	0.00449	CcSEcCtD
Rufinamide—Agitation—Temozolomide—melanoma	0.000253	0.00448	CcSEcCtD
Rufinamide—Vertigo—Temozolomide—melanoma	0.000247	0.00438	CcSEcCtD
Rufinamide—Convulsion—Carmustine—melanoma	0.000247	0.00437	CcSEcCtD
Rufinamide—Infection—Dactinomycin—melanoma	0.000247	0.00437	CcSEcCtD
Rufinamide—Leukopenia—Temozolomide—melanoma	0.000246	0.00436	CcSEcCtD
Rufinamide—Neutropenia—Docetaxel—melanoma	0.000245	0.00435	CcSEcCtD
Rufinamide—Thrombocytopenia—Dactinomycin—melanoma	0.000243	0.00431	CcSEcCtD
Rufinamide—Anxiety—Carmustine—melanoma	0.000241	0.00428	CcSEcCtD
Rufinamide—Convulsion—Temozolomide—melanoma	0.000238	0.00422	CcSEcCtD
Rufinamide—Weight decreased—Docetaxel—melanoma	0.000237	0.00421	CcSEcCtD
Rufinamide—Anorexia—Dactinomycin—melanoma	0.000237	0.00419	CcSEcCtD
Rufinamide—Pneumonia—Docetaxel—melanoma	0.000235	0.00417	CcSEcCtD
Rufinamide—Infestation NOS—Docetaxel—melanoma	0.000234	0.00415	CcSEcCtD
Rufinamide—Infestation—Docetaxel—melanoma	0.000234	0.00415	CcSEcCtD
Rufinamide—Anxiety—Temozolomide—melanoma	0.000233	0.00413	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000233	0.00412	CcSEcCtD
Rufinamide—Decreased appetite—Bleomycin—melanoma	0.000231	0.0041	CcSEcCtD
Rufinamide—Infection—Carmustine—melanoma	0.000231	0.00409	CcSEcCtD
Rufinamide—Thrombocytopenia—Carmustine—melanoma	0.000227	0.00403	CcSEcCtD
Rufinamide—Infection—Temozolomide—melanoma	0.000223	0.00395	CcSEcCtD
Rufinamide—Anorexia—Carmustine—melanoma	0.000221	0.00392	CcSEcCtD
Rufinamide—Hepatobiliary disease—Docetaxel—melanoma	0.000221	0.00392	CcSEcCtD
Rufinamide—Epistaxis—Docetaxel—melanoma	0.000221	0.00391	CcSEcCtD
Rufinamide—Nervous system disorder—Temozolomide—melanoma	0.00022	0.0039	CcSEcCtD
Rufinamide—Thrombocytopenia—Temozolomide—melanoma	0.00022	0.00389	CcSEcCtD
Rufinamide—Skin disorder—Temozolomide—melanoma	0.000218	0.00386	CcSEcCtD
Rufinamide—Decreased appetite—Dactinomycin—melanoma	0.000216	0.00382	CcSEcCtD
Rufinamide—Fatigue—Dactinomycin—melanoma	0.000214	0.00379	CcSEcCtD
Rufinamide—Anorexia—Temozolomide—melanoma	0.000214	0.00379	CcSEcCtD
Rufinamide—Rhinitis—Docetaxel—melanoma	0.000211	0.00373	CcSEcCtD
Rufinamide—Insomnia—Carmustine—melanoma	0.00021	0.00372	CcSEcCtD
Rufinamide—Urinary tract disorder—Docetaxel—melanoma	0.000208	0.00368	CcSEcCtD
Rufinamide—Somnolence—Carmustine—melanoma	0.000207	0.00366	CcSEcCtD
Rufinamide—Urethral disorder—Docetaxel—melanoma	0.000206	0.00365	CcSEcCtD
Rufinamide—Insomnia—Temozolomide—melanoma	0.000203	0.0036	CcSEcCtD
Rufinamide—Decreased appetite—Carmustine—melanoma	0.000202	0.00358	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Carmustine—melanoma	0.000201	0.00355	CcSEcCtD
Rufinamide—Somnolence—Temozolomide—melanoma	0.0002	0.00354	CcSEcCtD
Rufinamide—Constipation—Carmustine—melanoma	0.000199	0.00352	CcSEcCtD
Rufinamide—Dyspepsia—Temozolomide—melanoma	0.000198	0.0035	CcSEcCtD
Rufinamide—Eye disorder—Docetaxel—melanoma	0.000196	0.00348	CcSEcCtD
Rufinamide—Hypersensitivity—Bleomycin—melanoma	0.000196	0.00347	CcSEcCtD
Rufinamide—Decreased appetite—Temozolomide—melanoma	0.000195	0.00346	CcSEcCtD
Rufinamide—Cardiac disorder—Docetaxel—melanoma	0.000195	0.00345	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Temozolomide—melanoma	0.000194	0.00343	CcSEcCtD
Rufinamide—Fatigue—Temozolomide—melanoma	0.000194	0.00343	CcSEcCtD
Rufinamide—Constipation—Temozolomide—melanoma	0.000192	0.0034	CcSEcCtD
Rufinamide—Asthenia—Bleomycin—melanoma	0.000191	0.00338	CcSEcCtD
Rufinamide—Immune system disorder—Docetaxel—melanoma	0.00019	0.00336	CcSEcCtD
Rufinamide—Mediastinal disorder—Docetaxel—melanoma	0.000189	0.00336	CcSEcCtD
Rufinamide—Pruritus—Bleomycin—melanoma	0.000188	0.00334	CcSEcCtD
Rufinamide—Mental disorder—Docetaxel—melanoma	0.000184	0.00326	CcSEcCtD
Rufinamide—Malnutrition—Docetaxel—melanoma	0.000183	0.00324	CcSEcCtD
Rufinamide—Hypersensitivity—Dactinomycin—melanoma	0.000183	0.00324	CcSEcCtD
Rufinamide—Asthenia—Dactinomycin—melanoma	0.000178	0.00315	CcSEcCtD
Rufinamide—Back pain—Docetaxel—melanoma	0.000177	0.00313	CcSEcCtD
Rufinamide—Hypersensitivity—Carmustine—melanoma	0.000171	0.00303	CcSEcCtD
Rufinamide—Diarrhoea—Dactinomycin—melanoma	0.00017	0.00301	CcSEcCtD
Rufinamide—Vomiting—Bleomycin—melanoma	0.000169	0.003	CcSEcCtD
Rufinamide—Anaemia—Docetaxel—melanoma	0.000169	0.003	CcSEcCtD
Rufinamide—Rash—Bleomycin—melanoma	0.000168	0.00297	CcSEcCtD
Rufinamide—Dermatitis—Bleomycin—melanoma	0.000168	0.00297	CcSEcCtD
Rufinamide—Asthenia—Carmustine—melanoma	0.000167	0.00295	CcSEcCtD
Rufinamide—Hypersensitivity—Temozolomide—melanoma	0.000165	0.00293	CcSEcCtD
Rufinamide—Leukopenia—Docetaxel—melanoma	0.000164	0.0029	CcSEcCtD
Rufinamide—Asthenia—Temozolomide—melanoma	0.000161	0.00285	CcSEcCtD
Rufinamide—Diarrhoea—Carmustine—melanoma	0.000159	0.00282	CcSEcCtD
Rufinamide—Pruritus—Temozolomide—melanoma	0.000159	0.00281	CcSEcCtD
Rufinamide—Convulsion—Docetaxel—melanoma	0.000158	0.00281	CcSEcCtD
Rufinamide—Nausea—Bleomycin—melanoma	0.000158	0.0028	CcSEcCtD
Rufinamide—Vomiting—Dactinomycin—melanoma	0.000158	0.0028	CcSEcCtD
Rufinamide—Rash—Dactinomycin—melanoma	0.000156	0.00277	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000155	0.00274	CcSEcCtD
Rufinamide—Dizziness—Carmustine—melanoma	0.000154	0.00272	CcSEcCtD
Rufinamide—Diarrhoea—Temozolomide—melanoma	0.000154	0.00272	CcSEcCtD
Rufinamide—Dizziness—Temozolomide—melanoma	0.000148	0.00263	CcSEcCtD
Rufinamide—Infection—Docetaxel—melanoma	0.000148	0.00263	CcSEcCtD
Rufinamide—Vomiting—Carmustine—melanoma	0.000148	0.00262	CcSEcCtD
Rufinamide—Nausea—Dactinomycin—melanoma	0.000147	0.00261	CcSEcCtD
Rufinamide—Rash—Carmustine—melanoma	0.000146	0.00259	CcSEcCtD
Rufinamide—Nervous system disorder—Docetaxel—melanoma	0.000146	0.00259	CcSEcCtD
Rufinamide—Dermatitis—Carmustine—melanoma	0.000146	0.00259	CcSEcCtD
Rufinamide—Thrombocytopenia—Docetaxel—melanoma	0.000146	0.00259	CcSEcCtD
Rufinamide—Headache—Carmustine—melanoma	0.000146	0.00258	CcSEcCtD
Rufinamide—Skin disorder—Docetaxel—melanoma	0.000145	0.00257	CcSEcCtD
Rufinamide—Vomiting—Temozolomide—melanoma	0.000143	0.00253	CcSEcCtD
Rufinamide—Anorexia—Docetaxel—melanoma	0.000142	0.00252	CcSEcCtD
Rufinamide—Rash—Temozolomide—melanoma	0.000142	0.00251	CcSEcCtD
Rufinamide—Dermatitis—Temozolomide—melanoma	0.000141	0.00251	CcSEcCtD
Rufinamide—Headache—Temozolomide—melanoma	0.000141	0.00249	CcSEcCtD
Rufinamide—Nausea—Carmustine—melanoma	0.000138	0.00244	CcSEcCtD
Rufinamide—Insomnia—Docetaxel—melanoma	0.000135	0.00239	CcSEcCtD
Rufinamide—Nausea—Temozolomide—melanoma	0.000133	0.00236	CcSEcCtD
Rufinamide—Somnolence—Docetaxel—melanoma	0.000133	0.00235	CcSEcCtD
Rufinamide—Dyspepsia—Docetaxel—melanoma	0.000131	0.00233	CcSEcCtD
Rufinamide—Decreased appetite—Docetaxel—melanoma	0.00013	0.0023	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Docetaxel—melanoma	0.000129	0.00228	CcSEcCtD
Rufinamide—Fatigue—Docetaxel—melanoma	0.000129	0.00228	CcSEcCtD
Rufinamide—Constipation—Docetaxel—melanoma	0.000128	0.00226	CcSEcCtD
Rufinamide—Hypersensitivity—Docetaxel—melanoma	0.00011	0.00195	CcSEcCtD
Rufinamide—Asthenia—Docetaxel—melanoma	0.000107	0.0019	CcSEcCtD
Rufinamide—Pruritus—Docetaxel—melanoma	0.000106	0.00187	CcSEcCtD
Rufinamide—Diarrhoea—Docetaxel—melanoma	0.000102	0.00181	CcSEcCtD
Rufinamide—Dizziness—Docetaxel—melanoma	9.87e-05	0.00175	CcSEcCtD
Rufinamide—Vomiting—Docetaxel—melanoma	9.49e-05	0.00168	CcSEcCtD
Rufinamide—Rash—Docetaxel—melanoma	9.41e-05	0.00167	CcSEcCtD
Rufinamide—Dermatitis—Docetaxel—melanoma	9.4e-05	0.00167	CcSEcCtD
Rufinamide—Headache—Docetaxel—melanoma	9.35e-05	0.00166	CcSEcCtD
Rufinamide—Nausea—Docetaxel—melanoma	8.87e-05	0.00157	CcSEcCtD
Rufinamide—SCN5A—Developmental Biology—ERBB2—melanoma	1.25e-05	0.000101	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—melanoma	1.24e-05	9.97e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MAPK1—melanoma	1.23e-05	9.93e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MAPK1—melanoma	1.23e-05	9.93e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—melanoma	1.23e-05	9.93e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—melanoma	1.23e-05	9.93e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGF2—melanoma	1.23e-05	9.92e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SPARC—melanoma	1.23e-05	9.92e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—F2R—melanoma	1.23e-05	9.92e-05	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—melanoma	1.22e-05	9.83e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—melanoma	1.22e-05	9.81e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—melanoma	1.22e-05	9.81e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MAPK1—melanoma	1.21e-05	9.79e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—melanoma	1.21e-05	9.79e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—FN1—melanoma	1.21e-05	9.73e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—melanoma	1.21e-05	9.73e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—melanoma	1.21e-05	9.73e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLCB4—melanoma	1.19e-05	9.58e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—melanoma	1.17e-05	9.46e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—melanoma	1.17e-05	9.46e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—melanoma	1.16e-05	9.38e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—melanoma	1.16e-05	9.38e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PIK3CA—melanoma	1.15e-05	9.32e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CG—melanoma	1.15e-05	9.31e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HSPA5—melanoma	1.15e-05	9.28e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MDM2—melanoma	1.15e-05	9.28e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—melanoma	1.15e-05	9.24e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—EGF—melanoma	1.14e-05	9.21e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ERBB2—melanoma	1.13e-05	9.15e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—GAB2—melanoma	1.12e-05	9.07e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—GNA11—melanoma	1.12e-05	9.07e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CB—melanoma	1.12e-05	9.03e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC6A11—melanoma	1.12e-05	9.01e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIP4K2A—melanoma	1.12e-05	9.01e-05	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—melanoma	1.12e-05	9e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CTNNB1—melanoma	1.09e-05	8.81e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTAP—melanoma	1.09e-05	8.77e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.08e-05	8.75e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL8—melanoma	1.08e-05	8.68e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—melanoma	1.07e-05	8.64e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—melanoma	1.07e-05	8.62e-05	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6—melanoma	1.07e-05	8.62e-05	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—melanoma	1.07e-05	8.61e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NFKB1—melanoma	1.06e-05	8.55e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HDAC2—melanoma	1.06e-05	8.53e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IGF1—melanoma	1.06e-05	8.53e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1B—melanoma	1.05e-05	8.48e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—GNAQ—melanoma	1.05e-05	8.44e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CD44—melanoma	1.05e-05	8.44e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ITGA4—melanoma	1.05e-05	8.44e-05	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—melanoma	1.04e-05	8.38e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNB1—melanoma	1.04e-05	8.37e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CASP3—melanoma	1.03e-05	8.31e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2—melanoma	1.03e-05	8.3e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—melanoma	1.02e-05	8.27e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—melanoma	1.02e-05	8.27e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—melanoma	1.02e-05	8.25e-05	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—melanoma	1.02e-05	8.24e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLCB4—melanoma	1.02e-05	8.24e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CD—melanoma	1.01e-05	8.19e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNA1—melanoma	1.01e-05	8.17e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—melanoma	1e-05	8.09e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	1e-05	8.08e-05	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—melanoma	9.97e-06	8.05e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CTNNB1—melanoma	9.92e-06	8.01e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—melanoma	9.88e-06	7.98e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—melanoma	9.88e-06	7.98e-05	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—melanoma	9.85e-06	7.95e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SYK—melanoma	9.83e-06	7.93e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—melanoma	9.81e-06	7.92e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—melanoma	9.81e-06	7.92e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—melanoma	9.74e-06	7.86e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—melanoma	9.73e-06	7.85e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1A—melanoma	9.69e-06	7.82e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PHGDH—melanoma	9.68e-06	7.81e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LUM—melanoma	9.68e-06	7.81e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—melanoma	9.67e-06	7.8e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT3—melanoma	9.65e-06	7.78e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ITGAV—melanoma	9.65e-06	7.78e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NFKB1—melanoma	9.62e-06	7.77e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—melanoma	9.61e-06	7.76e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIP4K2A—melanoma	9.59e-06	7.74e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC6A11—melanoma	9.59e-06	7.74e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—melanoma	9.52e-06	7.68e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—melanoma	9.5e-06	7.66e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HPSE—melanoma	9.49e-06	7.66e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—melanoma	9.46e-06	7.63e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—melanoma	9.46e-06	7.63e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—melanoma	9.43e-06	7.61e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNA2—melanoma	9.42e-06	7.6e-05	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—melanoma	9.42e-06	7.6e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	9.37e-06	7.56e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTAP—melanoma	9.33e-06	7.53e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—melanoma	9.32e-06	7.52e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CUBN—melanoma	9.32e-06	7.52e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	9.12e-06	7.36e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MAPK3—melanoma	9.09e-06	7.34e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—melanoma	9.05e-06	7.3e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—melanoma	9.05e-06	7.3e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BSG—melanoma	9e-06	7.26e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SDHD—melanoma	9e-06	7.26e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CSPG4—melanoma	9e-06	7.26e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	8.84e-06	7.14e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ITGB1—melanoma	8.76e-06	7.07e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—melanoma	8.73e-06	7.05e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—melanoma	8.73e-06	7.04e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—melanoma	8.73e-06	7.04e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPAM—melanoma	8.72e-06	7.03e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MAPK1—melanoma	8.65e-06	6.98e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—melanoma	8.65e-06	6.98e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—melanoma	8.65e-06	6.98e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—melanoma	8.63e-06	6.96e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ACER3—melanoma	8.55e-06	6.9e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PHGDH—melanoma	8.32e-06	6.71e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LUM—melanoma	8.32e-06	6.71e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK3—melanoma	8.26e-06	6.67e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—melanoma	8.24e-06	6.65e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—melanoma	8.17e-06	6.6e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HPSE—melanoma	8.16e-06	6.58e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	8.12e-06	6.55e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—melanoma	8.04e-06	6.49e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HGF—melanoma	8.01e-06	6.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CUBN—melanoma	8.01e-06	6.46e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CSF2—melanoma	7.92e-06	6.39e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK1—melanoma	7.86e-06	6.35e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—melanoma	7.86e-06	6.34e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UGT2B10—melanoma	7.82e-06	6.31e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SDHD—melanoma	7.73e-06	6.24e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BSG—melanoma	7.73e-06	6.24e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CSPG4—melanoma	7.73e-06	6.24e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ITGB3—melanoma	7.59e-06	6.13e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PRKCA—melanoma	7.59e-06	6.13e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPAM—melanoma	7.49e-06	6.05e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—melanoma	7.43e-06	5.99e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLA2G6—melanoma	7.41e-06	5.98e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HS3ST5—melanoma	7.27e-06	5.87e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	7.14e-06	5.77e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RAC1—melanoma	7.04e-06	5.68e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—melanoma	6.95e-06	5.61e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	6.9e-06	5.57e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—melanoma	6.82e-06	5.51e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MMP1—melanoma	6.81e-06	5.5e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CDK2—melanoma	6.69e-06	5.4e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—VCAN—melanoma	6.66e-06	5.37e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—melanoma	6.65e-06	5.37e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—melanoma	6.6e-06	5.33e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	6.53e-06	5.27e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLA2G6—melanoma	6.37e-06	5.14e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—melanoma	6.31e-06	5.09e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FN1—melanoma	6.22e-06	5.02e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	6.21e-06	5.01e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS2—melanoma	6.14e-06	4.96e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—melanoma	6.13e-06	4.95e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—melanoma	6.04e-06	4.88e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—melanoma	5.95e-06	4.8e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EGF—melanoma	5.88e-06	4.75e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—VCAN—melanoma	5.72e-06	4.62e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP17A1—melanoma	5.62e-06	4.53e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—melanoma	5.57e-06	4.5e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLCB4—melanoma	5.51e-06	4.45e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—melanoma	5.45e-06	4.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.42e-06	4.37e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	5.39e-06	4.35e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNA11—melanoma	5.3e-06	4.28e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CD—melanoma	5.23e-06	4.22e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.23e-06	4.22e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—FASN—melanoma	5.19e-06	4.19e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC6A11—melanoma	5.18e-06	4.18e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIP4K2A—melanoma	5.18e-06	4.18e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC5A5—melanoma	5.11e-06	4.12e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTAP—melanoma	5.04e-06	4.07e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNAQ—melanoma	4.93e-06	3.98e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CD44—melanoma	4.93e-06	3.98e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP17A1—melanoma	4.83e-06	3.9e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.76e-06	3.84e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1B1—melanoma	4.73e-06	3.82e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNA11—melanoma	4.56e-06	3.68e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CB—melanoma	4.56e-06	3.68e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PHGDH—melanoma	4.49e-06	3.62e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LUM—melanoma	4.49e-06	3.62e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—FASN—melanoma	4.46e-06	3.6e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HPSE—melanoma	4.4e-06	3.55e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	4.4e-06	3.55e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC5A5—melanoma	4.39e-06	3.54e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CUBN—melanoma	4.32e-06	3.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CD44—melanoma	4.24e-06	3.42e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNAQ—melanoma	4.24e-06	3.42e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—melanoma	4.19e-06	3.38e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SDHD—melanoma	4.17e-06	3.37e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BSG—melanoma	4.17e-06	3.37e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CSPG4—melanoma	4.17e-06	3.37e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.15e-06	3.35e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.11e-06	3.32e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1B1—melanoma	4.06e-06	3.28e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPAM—melanoma	4.04e-06	3.26e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—melanoma	3.89e-06	3.14e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.59e-06	2.89e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PRKCA—melanoma	3.58e-06	2.89e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—melanoma	3.56e-06	2.87e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ERCC2—melanoma	3.55e-06	2.87e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—melanoma	3.51e-06	2.84e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLA2G6—melanoma	3.44e-06	2.77e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK3—melanoma	3.37e-06	2.72e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—melanoma	3.35e-06	2.7e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK1—melanoma	3.2e-06	2.58e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—VCAN—melanoma	3.09e-06	2.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PRKCA—melanoma	3.08e-06	2.48e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ERCC2—melanoma	3.05e-06	2.46e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—melanoma	3.02e-06	2.44e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—melanoma	2.81e-06	2.26e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—melanoma	2.78e-06	2.24e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—melanoma	2.71e-06	2.19e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—melanoma	2.69e-06	2.17e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP17A1—melanoma	2.61e-06	2.1e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—melanoma	2.57e-06	2.07e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.53e-06	2.04e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CD—melanoma	2.47e-06	1.99e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNA11—melanoma	2.46e-06	1.99e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—melanoma	2.44e-06	1.97e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—melanoma	2.41e-06	1.95e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FASN—melanoma	2.41e-06	1.94e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A5—melanoma	2.37e-06	1.91e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—melanoma	2.33e-06	1.88e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CD44—melanoma	2.29e-06	1.85e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNAQ—melanoma	2.29e-06	1.85e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—melanoma	2.27e-06	1.83e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1B1—melanoma	2.19e-06	1.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CB—melanoma	2.15e-06	1.74e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—melanoma	2.13e-06	1.72e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CD—melanoma	2.12e-06	1.71e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—melanoma	1.86e-06	1.5e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CB—melanoma	1.85e-06	1.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—melanoma	1.83e-06	1.48e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—melanoma	1.81e-06	1.46e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PRKCA—melanoma	1.66e-06	1.34e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ERCC2—melanoma	1.65e-06	1.33e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—melanoma	1.6e-06	1.29e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—melanoma	1.31e-06	1.06e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—melanoma	1.3e-06	1.05e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—melanoma	1.26e-06	1.01e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CD—melanoma	1.14e-06	9.24e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—melanoma	1.13e-06	9.12e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—melanoma	1.13e-06	9.09e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—melanoma	1.07e-06	8.64e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CB—melanoma	9.98e-07	8.05e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—melanoma	9.88e-07	7.98e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—melanoma	9.2e-07	7.43e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—melanoma	8.62e-07	6.96e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—melanoma	6.08e-07	4.91e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—melanoma	4.97e-07	4.01e-06	CbGpPWpGaD
